Share Twitter LinkedIn Facebook Email Angela Fleischman MD PhD UC Irvine discusses Disease Modifying Agents on the Horizon for MPN Hope to impact, intervene, & change course of disease progression early at MOASCs Spotlight On Hematology in Huntington Beach 2018.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read